What Was and Was Not Studied: Tone-Evening Ingredients on Deeper Skin

Which tone-evening skincare ingredients were actually studied on dark skin? Glycolic acid was, as in-clinic peels at up to 70 percent, and lactic acid at up to 92 percent. Niacinamide and alpha-arbutin were, but only on the underarm or inside multi-active formulas. Kojic acid and ascorbyl glucoside have no study that records skin type.

Opuliss Skin, the skincare line of the online beauty house Opuliss, uses six tone-evening ingredients: glycolic acid, lactic acid, niacinamide, alpha-arbutin, kojic acid and ascorbyl glucoside. This page counts what each was tested on, after earlier pages on who was in the trials and who is enrolled in dermatology trials.

How this page counted the studies

A study counted as a row only if it passed three tests. It tested the ingredient on its own, or inside a formula whose other ingredients are stated. Its own summary records Fitzpatrick type IV, V or VI skin, the deeper half of the scale. And it measured the look of dark spots or the evenness of tone. A row built on a formula is marked as one below, because its reading belongs to the formula, not the ingredient in it.

We searched PubMed in September 2026 for human studies of each ingredient and read every summary that mentioned deeper skin. A summary that records only a nationality does not count, because a result travels with the people it was measured on. This counts what the search found, not everything that exists.

Glycolic and lactic acid: studied on deeper skin, as clinic peels

The two acids have the most rows, and every row is an in-clinic peel. In one trial on type IV to VI skin, both groups used the same twice-daily gel carrying 10 percent glycolic acid alongside two prescription actives, and one group also had six glycolic peels at up to 68 percent. The peel group trended toward faster and greater improvement in the look of dark marks, and its unmarked skin also grew paler, which matters to a reader who wants an even look rather than a different one.¹ On type IV and V skin, a 70 percent glycolic peel went on the whole face, one side of which had been prepared first with microdermabrasion. Scores for the area and darkness of facial dark patches fell on both sides, and further on the prepared side.² A 35 percent peel on the same skin types was studied for comfort, not tone: redness, itch and pain afterwards.³

Lactic acid follows the same pattern. On type IV skin, a 92 percent lactic acid peel every three weeks lowered scores for the area and darkness of facial dark patches.⁴ On type IV and V skin, a 92 percent lactic peel on shallow textural scarring was followed by improvement in texture, pigmentation and overall look.⁵ One topical study sits just outside the count: on medium to dark skin, as its summary puts it, 8.8 percent lactic acid used alone for twelve weeks made no significant difference to skin pigmentation.⁶

None of this describes a 3.5 percent leave-on toner, which stays on the skin at home.

Niacinamide and alpha-arbutin: one row on the body, and face rows that belong to a formula

Niacinamide has two rows. A 4 percent niacinamide emulsion was tested alone against a placebo on the underarms of young women with phototypes III to V, where the skin was darker than its surroundings. After nine weeks, instrument readings of underarm colour improved significantly more with niacinamide than with placebo, the clinicians' rate of good to excellent response ran the same way, and a prescription comparator cream did better still.⁷ The second row is a face serum carrying niacinamide with tranexamic acid and lotus sprout extract: most of the women in its study had type IV to VI skin, and scores for uneven-looking tone and rough texture improved over sixteen weeks.⁸ Its other ingredients are stated, so it counts, but the reading belongs to the serum, and the wider case for niacinamide has its own page.

Alpha-arbutin has one row, and it is a formula too. A twice-daily face formula carrying alpha-arbutin at 2 percent with a second glucoside, trihydroxybenzoic acid glucoside, at 10 percent, plus a daily sunscreen, was used for ninety days by Indian women with facial dark spots. The colour difference between each spot and the skin around it narrowed by 8.7 percent, and a chromameter reading of skin-tone evenness improved by 19 percent.⁹ Its summary records Fitzpatrick types III and IV, the shallow edge of the deeper half, and with no comparison group the reading belongs to the whole routine.

Two other arbutin studies sit outside it. One applied single ingredients in an oil-based dispersion to healthy volunteers in skin of colour for six weeks: only 5 percent arbutin differed from the inactive control on pigment readings, but its summary names no form of arbutin and it measured healthy skin, not dark spots.¹⁰ The study cited on the Opuliss serum page put 5 percent alpha-arbutin with 2 percent kojic acid against a prescription cream on the other half of the face. Over twelve weeks the two sides did not differ on the area and darkness of dark patches, on the physician's overall rating only the comparison side improved, and skin type is not recorded.¹¹

Kojic acid and ascorbyl glucoside: tested, but skin type not recorded

Kojic acid was tested on its own at 2 percent in Indian women, scored on the area and darkness of facial dark patches over sixteen weeks.¹² A 1 percent kojic acid cream was the single-ingredient arm of a four-arm trial scored the same way.¹³ Neither summary records skin type. The kojic acid limit has its own page.

Ascorbyl glucoside has no row. Its closest face study put 28 percent of an ascorbyl glucoside complex on the sun-related dark spots of Japanese women, against a placebo lotion on the other half of the face, and the look of those spots improved more over twenty-four weeks.¹⁴ A vitamin C study that did enrol type IV and V skin used a different form, driven in at a clinic by a mild current, and beat a 70 percent glycolic peel on the other half of the face.¹⁵

What the evidence shows and does not

The count, one line per ingredient:

• Glycolic acid: several rows on type IV to VI skin, every one an in-clinic peel at up to 70 percent.¹²
• Lactic acid: rows on type IV and V skin, every one a 92 percent peel.⁴⁵
• Niacinamide: two rows. One tested it alone, on the underarm.⁷ The face row is a multi-active serum.⁸
• Alpha-arbutin: one row, a formula: 2 percent alpha-arbutin with a second glucoside and a sunscreen, in type III and IV skin.⁹ Tested alone, arbutin has been measured only on healthy skin, form not named.¹⁰
• Kojic acid: no row. Where it was tested alone, the summaries found do not record skin type.¹²
• Ascorbyl glucoside: no row, and no study found on type IV to VI skin.¹⁴

What it shows: four of the six were measured on deeper skin. What it does not show: for any of the six, a single ingredient in a leave-on face product at home strength, measured on the look of dark spots in type IV to VI skin. The studies cited on the Opuliss kojic cream and vitamin C pages sit further out again: skin type unrecorded. None of this is a promise about a bottle.

The Opuliss products that use these ingredients

The MILD GLYCOLIC EXFOLIATING TONER is a 250 ml leave-on toner with glycolic acid at 3.5 percent. Its page tells Fitzpatrick IV to VI skin to start once a week, in the evening, with a broad-spectrum SPF 30 or higher daily.

The ALPHA-ARBUTIN BRIGHTENING SERUM is a 30 ml serum built around alpha-arbutin, the CELLULAR ANTI-AGING ASCORBYL GLUCOSIDE SERUM a 30 ml morning serum with ascorbyl glucoside at 2 percent and ferulic acid at 1 percent, and the KOJIC ACID FACE CREAM a 50 ml moisturiser built on kojic acid. Neither the arbutin serum nor the kojic cream states its active's percentage, so neither can be matched to a strength above.

Each of the four pages advises a 24-hour patch test on the inner forearm first. The glycolic acid and niacinamide glossary entries carry plain definitions.

Frequently Asked Questions

References

1. Burns RL, Prevost-Blank PL, Lawry MA, et al. Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study. Dermatol Surg. 1997, 23(3):171-174. DOI 10.1111/j.1524-4725.1997.tb00014.x. PubMed PMID 9145958 (Burns 1997).
2. Abdel-Motaleb AA, Bakr RM. Microdermabrasion assisted delivery of glycolic acid 70% peel for the treatment of melasma in dark-skinned patients. Dermatol Ther. 2021, 34(4):e15025. DOI 10.1111/dth.15025. PubMed PMID 34089564 (Abdel-Motaleb 2021).
3. Sitohang IBS, Rahmayunita G, Hosfiar VA, et al. Effectiveness of water as the neutralising agent for glycolic acid peels in skin phototypes IV-V. Australas J Dermatol. 2021, 62(2):e212-e216. DOI 10.1111/ajd.13486. PubMed PMID 33070326 (Sitohang 2021).
4. Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg. 2005, 31(2):149-154. DOI 10.1111/j.1524-4725.2005.31035. PubMed PMID 15762205 (Sharquie 2005).
5. Sachdeva S. Lactic acid peeling in superficial acne scarring in Indian skin. J Cosmet Dermatol. 2010, 9(3):246-248. DOI 10.1111/j.1473-2165.2010.00513.x. PubMed PMID 20883299 (Sachdeva 2010).
6. Smith WP. The effects of topical l(+) lactic Acid and ascorbic Acid on skin whitening. Int J Cosmet Sci. 1999, 21(1):33-40. DOI 10.1046/j.1467-2494.1999.196561.x. PubMed PMID 18505528 (Smith 1999).
7. Castanedo-Cazares JP, Lárraga-Piñones G, Ehnis-Pérez A, et al. Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study. Clin Cosmet Investig Dermatol. 2013, 6:29-36. DOI 10.2147/CCID.S39246. PubMed PMID 23355788 (Castanedo-Cazares 2013).
8. Grimes P, Dias S, Huang P, et al. Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation. J Drugs Dermatol. 2026, 25(7):596-604. DOI 10.36849/JDD.9644. PubMed PMID 42406361 (Grimes 2026).
9. Gabhane M, Patil R, Dharmadhikari S, et al. Efficacy and Safety of a Topical Formulation Containing Trihydroxybenzoic Acid Glucoside and α-Arbutin, Applied Along With a Sunscreen: A Noncomparative, Prospective, Interventional Study in Indian Females With Facial Melasma or Dark Spots. J Cosmet Dermatol. 2025, 24(2):e70017. DOI 10.1111/jocd.70017. PubMed PMID 39943675 (Gabhane 2025).
10. Liyanage A, Liyanage G, Sirimanna G, et al. Comparative Study on Depigmenting Agents in Skin of Color. J Clin Aesthet Dermatol. 2022, 15(2):12-17. PubMed PMID 35309879 (Liyanage 2022).
11. Tantanasrigul P, Sripha A, Chongmelaxme B. The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study. J Cosmet Dermatol. 2025, 24(1):e16562. DOI 10.1111/jocd.16562. PubMed PMID 39555866 (Tantanasrigul 2025).
12. Patil R, Dhoot D, Balasubramanian A, et al. Comparison of the Effectiveness and Safety of 5% Cysteamine and 2% Kojic Acid Creams in the Treatment of Melasma in Indian Adult Females. Cureus. 2025, 17(3):e81330. DOI 10.7759/cureus.81330. PubMed PMID 40296942 (Patil 2025).
13. Deo KS, Dash KN, Sharma YK, et al. Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety. Indian J Dermatol. 2013, 58(4):281-285. DOI 10.4103/0019-5154.113940. PubMed PMID 23918998 (Deo 2013).
14. Takada M, Numano K, Nakano M, et al. Treatment with Ascorbyl Glucoside-Arginine Complex Ameliorates Solar Lentigos. Int J Mol Sci. 2024, 25(24):13453. DOI 10.3390/ijms252413453. PubMed PMID 39769217 (Takada 2024).
15. Sobhi RM, Sobhi AM. A single-blinded comparative study between the use of glycolic acid 70% peel and the use of topical nanosome vitamin C iontophoresis in the treatment of melasma. J Cosmet Dermatol. 2012, 11(1):65-71. DOI 10.1111/j.1473-2165.2011.00599.x. PubMed PMID 22360337 (Sobhi 2012).